Clinical Trial Update: Corneal Crosslinking in Keratoconus and Corneal Ectasia [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/phase 3 trial of corneal crosslinking for progressive keratoconus and corneal ectasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Snippet

Sponsor: Ohio State University | Conditions: Progressive Keratoconus, Corneal Ectasia | Phase 2, Phase 3 | Status: WITHDRAWN